Daphne Lainson specializes in securing patent protection for chemical, pharmaceutical and biotechnology related inventions for over a decade. She advises clients on pharmaceutical regulatory law, including providing strategic advice during patent prosecution and following patent grant for both pharmaceuticals and biologics. She is called upon to advise innovative pharmaceutical and biopharmaceutical companies in matters relating to the Patented Medicines (Notice of Compliance) Regulations and the Patented Medicine Prices Review Board. She was named as one of Canada's 2012 Lexpert "Rising Stars: Leading Lawyers Under 40", awarded Ottawa Business woman of the Year 2011 in the professional category by the Women's Business Network of Ottawa, and is listed annually in The Best Lawyers in Canada and Managing Intellectual Property’s IP Stars Handbook: Patents. She is an AIPLA Fellow, Vice-Chair of the AIPLA Food and Drug Law Committee (past co-Chair of the Japan Practice Committee and past chair of the Mentoring Committee and the Women in Intellectual Property Law Committee of the AIPLA). BSc Hons (Chemistry); MSc (Chemistry); LLB. Registered Patent and Trademark Agent. Called to the Ontario Bar in 2001.